National HTA Medical Device Program (PNHTA‑MD) 2026–2028

Technological innovation must advance hand in hand with sustainability and clinical validation. This Focus examines the National HTA Programme for Medical Devices (PNHTA‑MD) 2026–2028, outlining the new guidelines for the evaluation of health technologies in Italy

The document shows how HTA has now become a true strategic lever for both manufacturers and the healthcare system

Fully understanding the Programme makes it possible to anticipate market‑access requirements, optimise the value of technologies, and accelerate the introduction of innovation into the National Health Service, while minimising regulatory and economic risks.